Trade ACRS anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Aclaris Therapeutics, Inc. (ACRS) is trading at US$6.05, down 2.03% today as of Sep 8, 14:20 EDT. The company has a market capitalisation of US$943.54M. Over the past 52 weeks, ACRS has traded between US$1.74 and US$6.60. On Syfe you can trade ACRS with $0 commission and add it to your watchlist.
| Previous close | US$6.17 |
|---|---|
| Market cap | US$943.54M |
| 52-week range | US$1.74 – US$6.60 |
| Volume | 1.75M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Wayne, PA.
Year: 2015
-- Earnings Flash (ACRS) Aclaris Therapeutics, Inc. Reports Q2 Revenue $1.6M, vs. FactSet Est of $1.4M
Aug 6, 11:16 AM · MT Newswires
-- Earnings Flash (ACRS) Aclaris Therapeutics Posts Q2 Net Loss $0.15 a Share, vs. FactSet Est of $0.16 Loss
Aug 6, 11:03 AM · MT Newswires
Wedbush Raises Price Target on Aclaris Therapeutics to $10 From $8, Keeps Outperform Rating
Apr 29, 11:01 AM · MT Newswires
Aclaris Therapeutics Insider Sold Shares Worth $1,359,000, According to a Recent SEC Filing
Apr 28, 7:06 AM · MT Newswires
Aclaris Therapeutics, Inc. (ACRS) stock is trading at US$6.05, -2.03% from the previous close of US$6.17.
The market cap for Aclaris Therapeutics, Inc. (ACRS) stock is approximately US$943.54M.
The 52-week high for Aclaris Therapeutics, Inc. (ACRS) stock is US$6.60.
The 52-week low for Aclaris Therapeutics, Inc. (ACRS) stock is US$1.74.
Aclaris Therapeutics, Inc. (ACRS) does not currently pay a dividend.
Stay on top of ACRS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
